Trial Profile
Ibuprofen/famotidine, commercially available vs phase III fixed combination formulation, in healthy subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Feb 2011
Price :
$35
*
At a glance
- Drugs Ibuprofen/famotidine (Primary) ; Ibuprofen
- Indications Arthritis; Musculoskeletal pain; NSAID-induced gastrointestinal damage
- Focus Pharmacokinetics
- Sponsors Horizon Pharma USA
- 07 Feb 2011 Not the official study title.
- 27 May 2010 New trial record